Skip to content
Peptide research

Sermorelin

Also known as Geref · GRF 1-29
Category
Growth Hormone
Administration routes
Injectable
Regulatory status
Not FDA-approved

What it is

A synthetic fragment of GHRH that prompts the pituitary to release growth hormone, marketed for anti-aging, body composition, and sleep. It reliably raises GH, but the anti-aging benefits rest on weak human evidence; the strongest data is in pediatric growth. Injection-site reactions hit roughly 1 in 6, hypothyroidism and fluid retention can occur, and long-term anti-aging safety is unstudied. Supplied through compounding pharmacies and banned by WADA.

Read Full record

Studied uses & evidence

Studied uses(7)

  • Natural GH stimulation

    High

    Human trials show pulsatile GH release; one adult sermorelin trial doubled mean 24-hour GH and raised IGF-1 by about 34%.

  • Body composition

    Low

    Fat loss and lean gains seen mainly with a related molecule, not sermorelin directly.

  • Cognitive function

    Medium

    Human trials report better executive function and overall cognition in older adults.

Evidence limits

Evidence Level
Limited Clinical

Strongest evidence concerns pediatric GH deficiency. Adult evidence is limited and molecule-specific: a sermorelin cognition trial had 89 completers, while the 152-person cognition trial used tesamorelin. Studies of modified GHRH analogues should be identified separately.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

Do not use if

  • Active cancer

    High

    GH stimulation via GHRH pathway may promote tumor growth.

  • Pituitary damage

    High

    Requires functional pituitary to produce GH. Ineffective with pituitary damage.

  • Diabetic retinopathy

    High

    GH/IGF-1 elevation can worsen proliferative retinopathy.

Risk summary(5)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Injection site reactions (~1 in 6 patients)

    High
  • Hypothyroidism observed in 6.5% of clinical study patients

    Moderate
  • Potential GH-related effects: water retention, joint pain

    Moderate
  • Large-scale long-term safety data for off-label anti-aging use lacking

    High
  • WADA banned for competitive athletes

    High
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.